VS5-13289-96842
2 vaccinations
6 coded responses
21 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 483 / MI
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 1 — Pfizer-BioNTech
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Report sent to call center — days 1–6 daily, dose 1Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-01-23
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Congestion, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion — Feeling: GoodFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion — Feeling: Fair · Headache, Fatigue or tirednessFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Survey response — day 7, dose 1MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · HeadacheFree text: Runny nose, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-09
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-02-11
- 2021-02-12
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-24
- 2021-05-11
- 2021-08-12
-
2022-02-09
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-11
Call successfulParticipant prefers to complete VAERS report online
- 2022-11-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-22 | Unsuccessful | |
| 2022-02-09 | Successful 2022-02-11 |
Participant prefers to complete VAERS report online |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat
Systemic reaction (other): Congestion, sore throat
Systemic reaction (other): Congestion
Systemic reaction (other): Congestion
Release 2 — day 7, dose 1
Systemic reaction (other): Runny nose, congestion
Release 11 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release